| Emily
Burdett obtained a B.S. in Chemical Engineering in
May 2006 from the
University of Oklahoma. Emily began her Ph.D.
pursuit as part
of the
Mikos Research Group in the Bioengineering
Department at Rice
University in August 2007. She is
currently developing a 3D in vitro Ewing’s
sarcoma
growth model for use as a preclinical cancer drug
screen. |
